TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Proportion of patients with change in UDI-6 score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mucosal-plaque index (MPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of epidural catheter localisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence rate of adverse event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Grades of all the Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Within-person Default Mode Network (DMN) Connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Treatment decision at the last visit
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: average scores of image quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of time in range 70-180 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of brain activity during motor task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in polyp burden over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: User device preference for level-ground walking
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: User device preference for stair ascent & descent
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: User device preference for sloped ground ascent & descent
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Area under the analyte concentration-time curve from time 0 and extrapolated to infinite time (AUC 0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Any adverse event, serious adverse event (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Post-dose PD20
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in albumin to creatinine ratio (ACR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Pain Catastrophizing Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Tampa Scale of Kinesiophobia
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Fasting serum C-peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of cognitive impairment diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Leg Muscle Strength Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Balance Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of treated eyes without additional IOP-lowering intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: effectiveness of psychoeducation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of patients who achieved ACR20
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cornell Musculoskeletal Discomfort Questionnaire (CMDQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Brief Symptom Inventory (BSI) (53 items)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to Advanced Respiratory Support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Motor Evoked Potential (MEP) Amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Postoperative stricture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BPD or Death reduction
Endpoint domain: Mortality/survival
Primary endpoint: Change in direct bilirubin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in indirect bilirubin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Motor symptom burden (time spent in the ON state without dyskinesias)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes of the wound area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Hernia rate
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Celiac Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FGF21 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean knowledge regarding mastitis care and management
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean practice regarding mastitis care and management
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Arthritis Self-Efficacy Scale (ASES)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Device success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decrease in the percent stenosis after balloon procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: No life-threatening arrhythmias
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of eating disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of repeated self-harm episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine jet conspicuity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uptake of LARC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients reported being satisfied with telehealth-supported care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in LARC continuation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distribution of SARS-CoV-2 clade and lineage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Motor skill for endoscopic tip control improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Cmax of digoxin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma AUC0-last of digoxin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma AUC0-inf of digoxin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Cmax,ss of Metformin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma AUC0-tau of Metformin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-rating about anosognosia for USN
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in implicit measures of anosognosia for USN
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Amplitude of auditory event-related potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Latency of auditory event-related potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Severity of stress symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: percentage of children achieving at least 5x10e6 CD34 cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Arterial partial pressure of oxygen (PaO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Movement Screening (FMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spielberger State-Trait Anxiety Inventory for children
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adolescent Spiritual Well-Being Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Second phase insulin secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Proportion of HIV self-testing users receiving counselling along with testing
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of days with activity-limiting pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in glycaemic management
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in N-back test performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Secondary fracture prevention of hip
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Atroshi-Lyrén 6-item symptoms scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline Mini-Mental State Examination (MMSE) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline Wechsler Memory Scale (WMS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline Trial Making Test A and B score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of Participants Who Are Free of Hereditary Angioedema (HAE) Attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Health Related Quality of Life (HRQoL) using EQ-5D-5L
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Health Related Quality of Life (HRQoL) using WPAI:GH
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: EQ-5D-5L Utility Index (UI) scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Psychiatry Appointments
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of iCBT Content Viewed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Health Coach Text Messages
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of subjects free of all safety events (Cohort 1)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of subjects free of all safety events (Cohort 2)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of subjects meeting pre-specified events (Cohort 1)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of subjects meeting pre-specified events (Cohort 2)
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of life (EORTC-QLQ-30) summary score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: femoral stem implant survivorship
Endpoint domain: Mortality/survival
Primary endpoint: Pain on the Numeric Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sacroiliac joint pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: shoulder abduction strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Constant-Murley shoulder outcome score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quick DASH
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Self-Care Behaviors in Heart Failure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Signs of incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complications related to investigational product
Endpoint domain: Adverse events/effects
Primary endpoint: sedative requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sexual Dysfunction (SD) incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SD-related distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Protein expression of LDHA enzyme
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protein expression of MCT-1/-4 transporters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Chronic Kidney Disease (CKD) based on eGFR at 3 years post cancer therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Prevalence of Chronic Kidney Disease (CKD) based on eGFR at 5 years post cancer therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Prevalence of Hypertension (HTN) from office blood pressure at 3 years post cancer therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of Hypertension (HTN) using Ambulatory Blood Pressure Measurement (ABPM) at 5 years post cancer therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from the Stress and anxiety to viral epidemics-6 (SAVE-6) at week 8
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from the Fear of COVID-19 scale (FCV-19) at week 8
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Successful spirometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Clinically useful spirometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reduction in Symptoms greater than or equal to 50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of spread of SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Location of epiploic appendagitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of tumor subgroups
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Immunoglobulin G (IgG) concentrations against Salmonella Typhi
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Immunoglobulin A (IgA) concentrations against Salmonella Typhi
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Neutralizing antibodies against Japanese encephalitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Past Week Pain Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Past Week Pain Interference
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of choices for CC during preference task
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Neurogenic Cough Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Analgesic use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gross motor coordination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients dying due to COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Mean duration of hospital stay for surviving patients
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: percentage change from baseline in total lean body mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival to discharge from the PICU
Endpoint domain: Mortality/survival
Primary endpoint: Change from baseline in seated SBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Immunohistology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Frequency of Dysfunctional bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot and Ankle Outcome Score (FAOS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: WOMAC Pain subscale
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Changes in aerobic performance (treadmill)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thickness of the submental muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hyolaryngeal displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odom's criteria score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acute sensation felt during injection: intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Paresthesia felt after injection: intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in NIH Toolbox-Cognition Battery (NIHTB-CB) Fluid Composite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Subjective Drinking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Network Functional Connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Thrombotic event incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Composite rate of all-stroke
Endpoint domain: Mortality/survival
Primary endpoint: Composite rate of life threatening or fatal bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Composite rate of acute kidney injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Composite rate of hospitalization due to device or procedure-related complication
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Composite rate of valve dysfunction requiring reintervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: All cause hospital readmissions
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Health related quality of life (EQ5D)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time needed for measurements
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Respiratory pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Patient hemodynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Menstrual Attitude Scale (MAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cooper 12-Minute Timed Run Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite Machine Strength Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of intra-operative imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of diabetic ketoacidosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Geometric mean titres (GMTs) of neutralizing antibody to SARS-CoV-2 Omicron strain (BA.1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion rates of neutralizing antibody to SARS-CoV-2 Omicron strain (BA.1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean titres (GMTs) of neutralizing antibody to SARS-CoV-2 Prototype strain (CZ strain)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Bone mineral density (BMD) z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skeletal muscle mass (SMM) z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Carotid artery intima-media thickness (cIMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Aneurysmal sac shrinkage and volume reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Disability worsening based on revised-MSFC scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alterations in adipose tissue phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Markers of white and brown/beige adipose tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Gene expression changes in adipocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum Observed Concentration (Cmax) of Inebilizumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve of Inebilizumab from Time 0 to 14 Days Post-dose (AUC0-14d)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Experiencing Treatment-emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs), and Adverse Events of Special Interest (AESIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Serum levels of follicle stimulating hormone (FSH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Total area under the curve (tAUC) of hunger ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes